Cadwalader allows sharing content.
Email to a friend or colleague:
From
To
Subject
Email At the risk of stating the obvious, fighting and prosecuting health care fraud are top priorities for the Federal Government, and the False Claims Act (“FCA”) is its weapon of choice in the battle. In a speech in June, Stuart Delery, the Acting Assistant Attorney General for the Department of Justice (“DOJ”) Civil Division, stated the DOJ has recovered over $11 billion under the FCA, including over $7.4 billion in health care fraud. The Federal Government has a willing and motivated ally: more than 630 qui tam matters were filed with the DOJ, over two-thirds of which allege false claims to government health care programs. These numbers represent the greatest number of lawsuits ever filed within a year in the 150-plus year history of the FCA. In only the latest example of the Department’s aggressive pursuit of FCA claims, on July 2, 2012, GlaxoSmithKline LLC (“GSK”) agreed to pay $3 billion to the Federal Government to settle FCA allegations. https://www.cadwalader.com/resources/clients-friends-memos/a-hat-trick-of-heightened-false-claims-act-risks-for-health-care-providers